NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX), an antibody-based combination immunotherapy company, today announced that CDX-1127, a preclinical therapeutic antibody program for oncology indications, will be the subject of a poster presentation at the 2010 American Association for Cancer Research (AACR) 101st Annual Meeting in Washington, DC on Wednesday, April 21, 2010. The presentation (poster #5343) is entitled “Development of Novel Anti-CD27 Human Antibodies with Therapeutic Potential”. The presentation is scheduled from 8:00 a.m. to 11:00 a.m. EDT in Exhibit Hall A-C at the Walter E. Washington Convention Center. Celldex will release data before U.S. financial markets open on Wednesday, April 21, 2010.
